Company will have 180 days of marketing exclusivity on the 500 mg strength PITTSBURGH, Jan. 30 (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food a…
Biopharmacueticals, Generics, FDA
Mylan, Mylan Pharmaceuticals, Divalproex, Abbott, Depakote

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER”
Leave a Comment